Howe & Rusling Inc Amgen Inc Transaction History

Howe & Rusling Inc

$1.09 Billion
Q2 2024

A detailed history of Howe & Rusling Inc transactions in Amgen Inc stock. As of the latest transaction made, Howe & Rusling Inc holds 4,707 shares of AMGN stock, worth $1.49 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

4,707

Previous 4,864 3.23%

Holding current value

$1.49 Million

Previous $1.38 Million 6.37%

% of portfolio

0.13%

Previous 0.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $41,251 - $50,131	-157 Reduced 3.23%	4,707 $1.47 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $54,849 - $66,210	-204 Reduced 4.03%	4,864 $1.38 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $4,091 - $4,615	16 Added 0.32%	5,068 $1.46 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $14,649 - $18,187	67 Added 1.34%	5,052 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $7,499 - $8,867	35 Added 0.71%	4,985 $1.11 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $43,577 - $53,113	193 Added 4.06%	4,950 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $129,630 - $164,711	-566 Reduced 10.63%	4,757 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $8,978 - $10,126	-40 Reduced 0.75%	5,323 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $381,594 - $424,647	1,654 Added 44.59%	5,363 $1.31 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $23,681 - $26,197	-108 Reduced 2.83%	3,709 $897,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $1,988 - $2,276	-10 Reduced 0.26%	3,817 $859,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $20,590 - $24,123	-97 Reduced 2.47%	3,827 $814,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $11,679 - $12,957	-50 Reduced 1.26%	3,924 $956,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $22,634 - $26,377	-102 Reduced 2.5%	3,974 $989,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $35,053 - $41,742	162 Added 4.14%	4,076 $937,000
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $18,772 - $20,876	80 Added 2.09%	3,914 $995,000
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $62,507 - $76,705	-316 Reduced 7.61%	3,834 $904,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $6.43 Million - $8.53 Million	-35,294 Reduced 89.48%	4,150 $841,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $1.18 Million - $1.51 Million	-6,215 Reduced 13.61%	39,444 $9.51 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $168,538 - $201,944	-968 Reduced 2.08%	45,659 $8.84 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $162,199 - $190,133	973 Added 2.13%	46,627 $8.59 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $273,113 - $307,858	1,510 Added 3.42%	45,654 $8.67 Million
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $7.34 Million - $8.56 Million	41,121 Added 1360.27%	44,144 $8.59 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $38,540 - $43,449	208 Added 7.39%	3,023 $627,000
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $9,132 - $10,258	-55 Reduced 1.92%	2,815 $520,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $174,343 - $203,742	-1,029 Reduced 26.39%	2,870 $489,000
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $5,907 - $6,600	-35 Reduced 0.89%	3,899 $678,000
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $658,118 - $751,394	3,934	3,934 $734,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account